Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.

Arai K, Homma T, Morikawa Y, Ubukata N, Tsuruoka H, Aoki K, Ishikawa H, Mizuno M, Sada T.

Eur J Pharmacol. 2015 Jun 11;761:226-234. doi: 10.1016/j.ejphar.2015.06.015. [Epub ahead of print]

PMID:
26073023
2.

Demyelinating hypertrophic inferior alveolar nerve mimicking a nerve tumor.

Fujita H, Kokubun N, Sada T, Nagashima T, Komagamine T, Kawabe K, Hirata K.

Intern Med. 2015;54(9):1109-11. doi: 10.2169/internalmedicine.54.3512. Epub 2015 May 1.

3.

Evaluation of cutoff scores for the Parkinson's disease sleep scale-2.

Suzuki K, Miyamoto T, Miyamoto M, Suzuki S, Numao A, Watanabe Y, Tatsumoto M, Sakuta H, Watanabe Y, Fujita H, Iwanami M, Sada T, Kadowaki T, Hashimoto K, Trenkwalder C, Hirata K.

Acta Neurol Scand. 2015 Jun;131(6):426-30. doi: 10.1111/ane.12347. Epub 2014 Nov 17.

PMID:
25402773
4.

Design and fabrication of Ni nanowires having periodically hollow nanostructures.

Sada T, Fujigaya T, Nakashima N.

Nanoscale. 2014 Oct 7;6(19):11484-8. doi: 10.1039/c4nr02625j.

PMID:
25154433
5.

[Isolated cerebellar hemiatrophy: a case report].

Iwanami H, Iwasaki A, Okamura M, Kawasaki A, Sada T, Nakamura T, Kokubun N, Hirata K.

Brain Nerve. 2014 Jul;66(7):882-4. Japanese. No abstract available.

PMID:
24998834
6.

R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model.

Terashima H, Kato M, Ebisawa M, Kobayashi H, Suzuki K, Nezu Y, Sada T.

Eur J Pharmacol. 2014 Jul 5;734:60-6. doi: 10.1016/j.ejphar.2014.03.045. Epub 2014 Apr 12.

PMID:
24726873
7.

Nanometer-scale water droplet free from the constraint of reverse micelles at low temperatures.

Murakami H, Sada T, Yamada M, Harada M.

Phys Rev E Stat Nonlin Soft Matter Phys. 2013 Nov;88(5):052304. Epub 2013 Nov 7.

PMID:
24329261
8.

Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement.

Kokubun N, Sada T, Yuki N, Okabe M, Hirata K.

Eur Neurol. 2013;70(1-2):65-9. doi: 10.1159/000350287. Epub 2013 Jun 19.

PMID:
23796651
9.

Snoring is associated with an impaired motor function, disease severity and the quality of life but not with excessive daytime sleepiness in patients with Parkinson's disease.

Suzuki K, Miyamoto M, Miyamoto T, Suzuki S, Watanabe Y, Numao A, Iwanami M, Tatsumoto M, Sada T, Kadowaki T, Hashimoto K, Sakuta H, Hirata K.

Intern Med. 2013;52(8):863-9. Epub 2013 Apr 15.

10.

Probable rapid eye movement sleep behavior disorder, nocturnal disturbances and quality of life in patients with Parkinson's disease: a case-controlled study using the rapid eye movement sleep behavior disorder screening questionnaire.

Suzuki K, Miyamoto T, Miyamoto M, Watanabe Y, Suzuki S, Tatsumoto M, Iwanami M, Sada T, Kadowaki T, Numao A, Hashimoto K, Sakuta H, Hirata K.

BMC Neurol. 2013 Feb 9;13:18. doi: 10.1186/1471-2377-13-18.

11.

The 'Mickey Mouse ears' sign: a bilateral cerebral peduncular infarction.

Asakawa Y, Suzuki K, Takekawa H, Okamura M, Komagamine T, Kawasaki A, Yamamoto M, Sada T, Hirata K.

Eur J Neurol. 2013 Feb;20(2):e37-9. doi: 10.1111/ene.12027. No abstract available.

PMID:
23311510
12.

Tailor-made cell patterning using a near-infrared-responsive composite gel composed of agarose and carbon nanotubes.

Koga H, Sada T, Fujigaya T, Nakashima N, Nakazawa K.

Biofabrication. 2013 Mar;5(1):015010. doi: 10.1088/1758-5082/5/1/015010. Epub 2013 Jan 10.

PMID:
23302183
13.

Rab33a mediates anterograde vesicular transport for membrane exocytosis and axon outgrowth.

Nakazawa H, Sada T, Toriyama M, Tago K, Sugiura T, Fukuda M, Inagaki N.

J Neurosci. 2012 Sep 12;32(37):12712-25. doi: 10.1523/JNEUROSCI.0989-12.2012.

14.

Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.

Suzuki K, Miyamoto M, Miyamoto T, Tatsumoto M, Watanabe Y, Suzuki S, Iwanami M, Sada T, Kadowaki T, Numao A, Trenkwalder C, Hirata K.

J Neurol Sci. 2012 Jul 15;318(1-2):76-81. doi: 10.1016/j.jns.2012.03.022. Epub 2012 Apr 23.

PMID:
22534309
15.

Spironolactone, but not eplerenone, impairs glucose tolerance in a rat model of metabolic syndrome.

Homma T, Fujisawa M, Arai K, Ishii M, Sada T, Ikeda M.

J Vet Med Sci. 2012 Aug;74(8):1015-22. Epub 2012 Apr 13.

16.

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome.

Homma T, Sonoda H, Manabe K, Arai K, Mizuno M, Sada T, Ikeda M.

Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F750-61. doi: 10.1152/ajprenal.00494.2011. Epub 2011 Dec 7.

17.

Involvement of the capsular genu in reward-related feeding.

Suzuki K, Sada T, Nakamura T, Takekawa H, Hirata K.

J Neurol. 2012 May;259(5):993-4. doi: 10.1007/s00415-011-6304-6. Epub 2011 Nov 15. No abstract available.

PMID:
22083432
18.

Near-IR laser-triggered target cell collection using a carbon nanotube-based cell-cultured substrate.

Sada T, Fujigaya T, Niidome Y, Nakazawa K, Nakashima N.

ACS Nano. 2011 Jun 28;5(6):4414-21. doi: 10.1021/nn2012767. Epub 2011 Jun 8.

PMID:
21627128
19.

Association analysis of Toll-like receptor 7 gene polymorphisms and Behçet's disease in Japanese patients.

Sada T, Ota M, Katsuyama Y, Meguro A, Nomura E, Uemoto R, Nishide T, Okada E, Ohno S, Inoko H, Mizuki N.

Hum Immunol. 2011 Mar;72(3):269-72. doi: 10.1016/j.humimm.2010.12.007. Epub 2010 Dec 14.

PMID:
21167247
20.

A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats.

Terashima H, Kato M, Yasumo H, Tsuchida H, Mizuno M, Sada T.

Am J Physiol Renal Physiol. 2010 Oct;299(4):F792-801. doi: 10.1152/ajprenal.00141.2009. Epub 2010 Jul 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk